Background and aims: Therapeutic angiogenesis is a pivotal strategy for ischemic heart disease. The aim of the present study was to determine the effect and molecular mechanism of Shexiang Baoxin pills, a widely-used traditional Chinese medicine for ischemic heart disease, on angiogenesis in a rat model of myocardial infarction (MI). Methods: We used the occlusion of left anterior descending coronary artery of Sprague-Dawley rats as a model of MI. The MI rats were treated with distilled water, Shexiang Baoxin pills, or Shexiang Baoxin pills þ HET0016 (a selective blocker of the biosynthesis of 20-hydroxyeicosatetraenoic acid (20-HETE) at 10 mg/kg/day), respectively. Sham-operated rats were used as controls. Results: Treatment with Shexiang Baoxin pills increases the level of serum 20-HETE in MI rats, which can be suppressed by HET0016 treatment. Shexiang Baoxin pills shows cardio-protective effects on MI rats, including improving cardiac function, decreasing infarction area, and promoting angiogenesis in periinfarct area. The protective effects of Shexiang Baoxin pills are partly inhibited by HET0016. Furthermore, Shexiang Baoxin pills enhances the number of circulating endothelial progenitor cells (EPCs) and the expression of the vascular endothelial growth factor (VEGF), based on immunohistochemical analysis, in peri-infarct area of MI rats, which is partly suppressed by HET0016. Conclusions: Shexiang Baoxin pills may partially participate in angiogenesis in MI rats. The protective mechanism of Shexiang Baoxin pills may be mediated via up-regulation of 20-HETE, which promotes EPCs mobilization and VEGF expression.
Introduction
Myocardial infarction (MI) has become a major cause of hospitalization and mortality in China [1, 2] . The mortality by MI during the past two decades has been increasing, with more than 1 million deaths per year, and this trend is expected to accelerate, with the World Bank estimating that the number of individuals with MI in China will increase to 23 million by 2030 [3] . Rapid and improved treatment of MI has substantially reduced the mortality; that includes early myocardial reperfusion, effective antithrombotic therapy, and intensive evidence-based medication into routine clinical practice.
Shexiang Baoxin pills is a well-known Moschus-based traditional Chinese medicines composite formula widely used in clinical practice for the treatment of cardiovascular diseases including angina pectoris and MI [4, 5] . Yan and Jiang et al. reported that the main active ingredients of it are chenodeoxycholic acid, cholic acid, cinobufagin, deoxycholic acid, ginsenosideRb1, recibufogenin and ursodeoxycholic acid [6, 7] . Previous studies have reported that Shexiang Baoxin pills could reduce the myocardial ischemic area, the recurrence of angina pectoris, and cardiac events in patients with angina pectoris [8] . However, the exact mechanism is not completely known.
Previous experimental and clinical studies have demonstrated that Shexiang Baoxin pills shows a pro-angiogenic effect in periinfarct area in a rabbit model of MI [9] . Recently, myocardial angiogenesis has been recognized as one of the innovative therapeutic methods for the treatment of MI [10] . It promotes the development of new capillary networks through migration and proliferation of previously differentiated endothelial cells [11] , which can provide the supply of oxygen and nutrients to the ischemic regions of MI and improve compromised cardiac function [12, 13] . The paradigm to improve therapeutic angiogenesis has focused on enhancing the formation of neovessels from preexisting, terminally differentiated endothelial cells to accelerate neovascularization. Several reports have shown that endothelial progenitor cells (EPCs), precursors derived from bone marrow, have the capacity to differentiate into endothelial cells and incorporate into areas of neovascularization via vasculogenesis [14, 15] . EPCs can move to sites of ischemia and contribute to neovascularization in ischemic tissue [16] . Previous experimental and clinical studies have demonstrated that treatment of acute MI with EPCs results in a reduction in infarct size [17, 18] . An in-vitro study by Wu et al. showed that Shexiang Baoxin pills promotes the proliferation, migration, and angiogenesis of EPCs [19] . 20-Hydroxyeicosatetraenoic acid (20-HETE) is the u-hydroxylation product of arachidonic acid (AA) by cytochrome P450 (CYP) 4A and 4F [20, 21] . Guo et al. suggested that 20-HETE plays an important role in regulating the EPC functions associated with angiogenic responses [22] . Importantly, an in vitro study by Chen et al. demonstrated that 20-HETE promotes the proliferation and migration of EPCs [23] . Therefore, we hypothesized that the cardioprotective role of Shexiang Baoxin pills in angiogenesis is mediated by promoting 20-HETE-mediated EPCs mobilization. The aim of the study was to determine the pro-angiogenic effect of Shexiang Baoxin pills and the potential underlying mechanisms in a rat model of MI.
Materials and methods

Ethics statement
The experimental protocol was approved by the Animal Experimental Ethics Committee in Sun Yat-sen University. The animal study complied with the Guidelines for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 85e23, revised 1996).
MI model
Male Sprague-Dawley rats (250 ± 20 g) were acclimatized in a controlled environment with 12/12-h light/dark cycles. Rats were divided into 4 groups: sham-operated group (n ¼ 10), myocardial infarction (MI) group (n ¼ 10), MI þ Shexiang Baoxin pills and MI þ Shexiang Baoxin pills þ HET0016 (n ¼ 10). MI was induced by occlusion of the left anterior descending coronary artery as described previously [24] . Briefly, anesthesia was conducted by intraperitoneal injection with ketamine (40 mg/kg) and xylazine (5 mg/kg). Then, endotracheal intubation and mechanical entilation were performed. After left thoracotomy and peicardiotomy, the left anterior descending coronary artery was permanently occluded. Rats in MI þ Shexiang Baoxin pills group received a gavage of Shexiang Baoxin pills (25 mg/kg/d) [25] in distilled water for 8 weeks. HET0016 was given through intraperitoneal injection (10 mg/kg/day) [26] . Shexiang Baoxin pills was bought from Shanghai Hutchison Pharmaceuticals.
Echocardiography
Among the various cardiac contractility parameters, left ventricular (LV) ejection fraction (EF) and maximum dP/dt (dP/ dt(max)) are the simplest and most used, meanwhile EF is a more accurate measure of systolic dysfunction than dP/dt(max) in a swine model of MI [27] . So, transthoracic echocardiography (IU22, Philips, Amsterdam, Netherlands) was used to assess cardiac structural and functional changes 8 weeks after MI operation. We used pentobarbital (40 mg/kg intraperitoneally) for anesthesia. Left ventricular internal diameter at end-diastole (LVIDd), left ventricular internal diameter at end-systole (LVIDs), left ventricular fraction shortening (FS) and EF were recorded.
Measurement of infarction area
Eight weeks after MI operation, rats were anaesthetized with pentobarbital (40 mg/kg intraperitoneally) and sacrificed after blood draw. Body weight and left ventricular weight were recorded. The left ventricular tissues were embedded in paraffin after being fixed with 4% paraformaldehyde for 24 h. Cross sections of left ventricle were at the midline of the long axis of heart. HE and Masson staining were used to assess infarction area. The extent of the infarction area was calculated as the ratio of perimeter of infarction region to total perimeter of left ventricle with Image Proplus 5.0 software (Media Cybernetics, Bethesda, US).
Immumohistochemical staining
Immumohistochemical staining was performed as described previously [28] . To assess the microvessel density in the peri-infarct area of MI, tissue sections were incubated with the primary antibody of CD31 (Santa Cruz, California, US) followed by HRPconjugated secondary antibody and then staining with 3, 3diaminobenzidine (DAB). We obtained digital photomicrographs of the peri-infarct area. The number of microvessels in 10 random fields at 400Â magnification was measured and averaged. Immumohistochemical staining was also used to measure the expression of VEGF (Santa Cruz, California, US). We detected optical density of VEGF-positive cells in digital photomicrographs (400Â) in the periinfarct area using image-analysis software (Image J, NIH).
Western blot analysis
Heart extracts were lysed in RIPA buffer (50 mM Tris-HCL pH 7.4, 150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS) supplemented with complete protease inhibitor cocktail tablets (Roche). Cell debris and tissue sediment were removed by centrifugation at 12,000 rpm for 10 min. Lysates were separated by 10e12% SDS-PAGE gel, transferred to PVDF membranes (Millipore). CD31 (Santa Cruz, California, US), VEGF (Santa Cruz, California, US) proteins were detected by use of antibodies, and then by an HRPconjugated secondary antibody. The level of GAPDH (Cell Signaling Technology; 1:1000) protein was also measured as a loading control. The protein bands were visualized by the ECL detection system (Thermo, Boston, MA) and the densities of the bands were quantified and normalized against GAPDH by image software (Thermo).
Detection of serum 20-HETE
Serum 20-HETE level was detected with an ELISA kit (R&D, Detroit, Michigan, USA). The process was performed according to manufacturer's instructions.
Flow cytometry analysis of circulating EPCs
We used flow cytometry to detect circulating EPCs in rats 7 days after MI. Briefly, blood samples were drawn from the eye socket vein. Blood samples (100 ml) were incubated at 4 C for 30 min with fluorescent conjugated antibodies, including anti-CD34-PE (Santa Cruz, California, US), anti-CD133-FITC (Biorbyt, Cambridge, UK) and anti-VEGFR2-PE-Cy5 (Biorbyt, Cambridge, UK). Fluorescent conjugated isotype IgGs were used as controls. Then erythrocytes were eliminated via incubation with lysis buffer and washing with PBS. Cells labeled with fluorescence were counted with FACS flow cytometer (Becton Dickinson) and analyzed with Cell Quest Software. The percentage of EPCs defined as double-positive cells of CD34 þ CD133þ,CD34 þ VEGFR2þ and CD133 þ VEGFR2þ in monocytes (10,000 events) was calculated.
Statistical analysis
Normal distribution data was described as mean ± standard deviation (SD). Student's t-test was used to compare the differences between two groups. The comparison between multiple groups was performed using one-way ANOVA followed by a Bonferroni test. The SPSS version 13.0 (SPSS Inc. Chicago, IL, US) was used for statistical analyses. A two-tailed p-value <0.05 indicates significant difference.
Results
Shexiang Baoxin pills increases circulating 20-HETE in MI rats
The comparison of left ventricular weight and body weight among groups is shown in Fig. 1 . The rats in the MI group had lower body weight as compared to rats in the sham-operated group. Treatment with Shexiang Baoxin pills or HET0016 (a blocker of 20-HETE synthesis) did not affect body weight. There was no significant difference in left ventricular weight in rats given different treatments. Rats treated with Shexiang Baoxin pills under MI for 8 weeks increased serum 20-HETE levels, which were determined by ELISA assay. Notably, treatment with HET0016, a selective 20-HETE blocker, significantly reduced 20-HETE levels (Fig. 2 ). Fig. 3 shows the representative M-mode echocardiograms of rats given different treatments. Echocardiography showed that MI rats had increased LVIDd and LVIDs as compared to sham-operated rats, and Shexiang Baoxin pills ameliorated the changes in LVIDs in MI rats (Fig. 4) . Decreased EF adn FS, which indicate reduced cardiac function, were observed in MI rats. Rats treated with Shexiang Baoxin pills under MI showed significant improvement in cardiac function, whereas 20-HETE blockade by HET0016 partly suppressed the protective effect of Shexiang Baoxin pills on cardiac function. Fig. 5A shows the representative images of HE staining and Masson staining of cardiac slices of rats given different treatments. Administration of Shexiang Baoxin pills attenuated infarction area in MI rats, whereas the effect of Shexiang Baoxin pills on infarction area were suppressed by HET0016 (Fig. 5B ).
Shexiang Baoxin pills improve cardiac function and reduce infarction area in MI rats through up-regulation of 20-HETE
3.3. Shexiang Baoxin pills promotes angiogenesis in peri-infarct area in MI rats through up-regulation of 20-HETE Immumohistochemical staining with CD31 showed that Shexiang Baoxin pills promoted angiogenesis in peri-infarct area of rats under MI, while HET0016 suppressed the pro-angiogenic effect of Shexiang Baoxin pills (Fig. 6 ). We also detected the protein expression of CD31 (Fig. 7) . We found that Shexiang Baoxin pills could increase the level of CD31 in rats under MI, while HET0016 suppressed the effect of Shexiang Baoxin pills on CD31. These results suggest that Shexiang Baoxin pills promotes angiogenesis partially through up-regulation of 20-HETE levels.
Shexiang Baoxin pills increases the number of circulating EPCs and the expression of VEGF in peri-infarct area in MI rats
At day 7 after MI, Shexiang Baoxin pills significantly increased the number of circulating EPCs in rats under MI ( Table 1 ). The effect was suppressed by HET0016. Fig. 8 shows the representative images of immumohistochemical staining of VEGF in rats given different treatments. Shexiang Baoxin pills increased the expression of VEGF in peri-infarct area of rats 8 weeks after MI, whereas treatment with HET0016 attenuated the effect of Shexiang Baoxin pills on VEGF expression. We also detected the protein expression of VEGF ( Fig. 9 ). In accordance with the expectation, we reached the same results.
Discussion
In a meta-analysis of randomized controlled trials, Chung et al. reported that Chinese herbal medicine is found to be efficacious in lowering the risk of fatal and nonfatal cardiogenic shock, cardiac arrhythmia, myocardial reinfarction, heart failure, angina, and occurrence of total heart events, especially combined biomedicine [29] . Similar to the previous study, the present study demonstrates that Shexiang Baoxin pills improves cardiac function, and we also found that it can promote angiogenesis in peri-infarct area of rats under MI. Although it has been recognized that treatment with Shexiang Baoxin pills has beneficial effects in ischemic heart disease, the exact mechanism for these effects is still not clear. Here, for the first time, we show that the related mechanism of Shexiang Baoxin pills on angiogenesis in MI is mediated via 20-HETE-mediated EPCs mobilization.
Previous studies have demonstrated that Shexiang Baoxin pills has protective effects on cardiovascular diseases. Shexiang Baoxin pills was found to inhibit cardiac fibrosis in spontaneous hypertensive rats [30] . In a clinical study, treatment with Shexiang Baoxin pills attenuates the occurrence of angina pectoris and reduces the use of nitroglycerin in patients with angina pectoris [31] . The protective effects of Shexiang Baoxin pills on cardiac vasculature include dilating coronary arteries, improving endothelial cell function, and reducing the area of atherosclerotic plaque [32, 33] . Our results are consistent with a previous study [4] that Shexiang Baoxin pills could increase cardiac microvessel density in periinfarct area, reduce the infarction area, and improve cardiac function in MI rats.
It is well known that Shexiang Baoxin pills is a composite of seven medicinal materials or extracts. Some investigation has begun to evaluate the therapeutic effects of the bioactive components and the synergistic efficacy of Shexiang Baoxin pills on MI in rats. Li et al. reported that Shexiang Baoxin pills displayed better regulation efficacy than seven combined versions of these bioactive components in rat model of MI [34] . However, the specific mechanism of the pro-angiogenic effect of Shexiang Baoxin pills is still not clear and needs further investigation.
EPCs are generated in bone marrow, and these cells have the capacity to proliferate and migrate to sites of neovascularization, where they are differentiated into mature ECs [14] . The number of circulating EPCs and their angiogenic capacity are closely associated with cardiovascular events and mortality [35] . We found that Shexiang Baoxin pills could increased circulating numbers of EPCs as well as microvessel density in peri-infarct area in MI, suggesting that increasing EPCs may be an important factor to repair the cardiac damage under MI. Interestingly, an in vitro study by Wu et al. showed that Shexiang Baoxin pills promoted the proliferation, migration, and angiogenesis of EPCs [19] . These findings support the notion that Shexiang Baoxin pills could mobilize bone marrowderived EPCs to peripheral tissues and participate in angiogenesis.
Several pro-angiogenic factors, including VEGF and 20-HETE, have been implicated in the regulation of the mobilization of EPCs. Previous studies showed that 20-HETE has the capability to enhance the proliferation of endothelial cells (ECs) by activating VEGF pathway [20, 36] . In addition, 20-HETE blockade suppresses the pro-angiogenic effects of VEGF, epidermal growth factor and basic fibroblast growth factor [36] . Therefore, the pro-angiogenic Although 20-HETE shows the capacity of increasing proliferation of EPCs and promoting angiogenesis, the exact role of 20-HETE in the cardiovascular system is complicated [37] . For example, a previous study found that 20-HETE regulates blood pressure in a tissue-specific way and could be both pro-hypertensive and antihypertensive [38] . Another study found that 20-HETE has detrimental effects on cardiomyocytes and ECs [38] . The mechanisms of some TCMs, such as Shexiang Baoxin pills, are usually through a multi-target and multi-pathway mode due to different active ingredients [39] . Hence, the roles of 20-HETE on cardiac effect might be related to the dual-directional regulation effects of Shexiang Baoxin pills.
Besides, 20-HETE, epoxyeicosatrienoic acids (EETs) are other metabolites of AA metabolized by CYP epoxygenases, and these lipid mediators can increase coronary blood flow and protect the myocardium from ischemia-reperfusion injury [40] . However, these active lipid mediators are degraded to the corresponding dihydroxyeicosatrienoicacids (DHETs) by soluble epoxide hydrolase (sEH) [41] . Zhu et al. found that sEH blockade could prevent and reverse ischemic heart disease [42] . Thus, whether the effect of Shexiang Baoxin pills on angiogenesis related to the sEH/EETs pathway requires further investigation. There are some limitations in this study: 1) we did not compare the effect of Shexiang Baoxin pills with its main active ingredients and tested separately and 2) we did not determine the effect of Shexiang Baoxin pills on the expression and activity of CYP4A or CYP4F also 3) we did not explore whether the effect of Shexiang Baoxin pills on angiogenesis is related to angiopoietin. We will explore the effect of the main active ingredients of Shexiang Baoxin pills on angiogenesis in future studies.
Conclusions
In the present study, we demonstrate that Shexiang Baoxin pills reduces myocardial infarction area, and preserves cardiac function in a rat model of MI. The related mechanism for this biological activity may partially be through up-regulation of 20-HETE, which could increase the expression of VEGF and mobilize EPCs to participate in angiogenesis. Because Shexiang Baoxin pills is a compound consisting of different ingredients, the whole effect of Shexiang Baoxin pills in rats with MI may also be involved in other mechanisms. This calls for further studies to compare the effect of Shexiang Baoxin pills with its main active ingredients and explore related mechanisms.
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